China Universal Asset Management »

Springworks Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $699k 14k 49.25
2023-12-31 $264k 7.2k 36.48
2023-09-30 $37k 1.6k 22.95
2023-06-30 $22k 820 26.83
2023-03-31 $22k 847 25.97
2022-12-31 $16k 634 25.24
2022-09-30 $13k 463 28.08

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Springworks Therapeutics

Vanguard Group
Boxer Capital
OrbiMed Advisors
Marshall Wace
Maverick Capital
T. Rowe Price Associates
Deerfield Management Company
Point72 Asset Management
Arrowpoint Asset Management
Perceptive Advisors
Artal Group
Dimensional Fund Advisors
Fiera Capital Corporation
Jpmorgan Chase & Co
Victory Capital Management

View all funds holding Springworks Therapeutics